The U.S. Government Is Now a Quantum Shareholder With Equity in Nine Companies

IBM is building a factory for quantum chips. The Department of Commerce just became its first outside investor.

Anderon, IBM's new quantum foundry subsidiary backed by $1 billion in CHIPS Act funding and $1 billion of IBM's own cash, is the concrete centerpiece of the $2.013 billion quantum commitment Commerce announced May 21. Nine companies. Nine minority equity stakes. Nine architectures that cannot all be right about the best path to fault-tolerant quantum computing. IBM's piece of that is the clearest signal of what's actually being built: a 300-millimeter wafer facility in Albany, New York, structured as America's first pure-play quantum foundry — a contract manufacturer for superconducting qubit hardware that would serve IBM and, more importantly, third-party quantum hardware companies that currently have nowhere to go to fab their chips at scale, per IBM's announcement.

That is the more concrete version of the $2.013 billion commitment Commerce announced May 21. Nine companies, nine LOIs, nine minority equity stakes. IBM gets $1 billion. GlobalFoundries gets $375 million. Six others get $100 million each. Diraq gets up to $38 million. Per the NIST announcement, the money is spread across superconducting qubits, trapped ions, neutral atoms, silicon spins, and photonics — fundamentally incompatible architectures that the government is funding simultaneously because it cannot determine which will win. The equity stakes are real. The LOIs are signed. And now there is a foundry that, if it works, could collapse the time between a promising qubit design and a working device.

The pure-play foundry model is the underreported part of this. Quantum hardware companies have historically built their own fabrication pathways, partly because the processes are specialized and partly because nobody has offered an alternative. Anderon is attempting to be that alternative — a 300-millimeter wafer facility in Albany, New York, operated as a standalone company, serving the broader quantum ecosystem rather than just IBM's internal roadmap. Whether external customers actually materialize is the question Anderon's proponents need to answer. Quantum hardware startups have historically preferred to own their fabrication rather than outsource it. The foundry bet is that the capital intensity of building at 300mm forces a different calculation.

Commerce's equity stakes give it a financial interest in the outcome of that bet. Under the LOIs, the department will hold minority non-controlling positions in each of the nine companies — meaning it has a stake in PsiQuantum's photonic architecture and Rigetti's superconducting approach simultaneously, companies that are, from a commercial standpoint, competitors. "This is a portfolio approach to strengthen and accelerate U.S. leadership across multiple quantum modalities at once," said Bill Frauenhofer, executive director of semiconductor investment and innovation at Commerce, in the NIST announcement. Per MeriTalk, "the department will receive a minority and non-controlling equity stake in each company." The framing was presented as industrial policy. It is also, structurally, a venture capital strategy — one where the government's motive is national security rather than return on investment, but where the cap-table presence gives it visibility into licensing discussions and exit pathways that a standard procurement contract would never provide.

The $850 billion figure IBM cited for quantum's estimated economic value by 2040 should be handled carefully. It is IBM's number, attached to IBM's subsidiary, used to justify IBM's CHIPS award and IBM's own co-investment. That is not independent analysis. The economic potential of quantum computing, whenever it arrives, is genuinely contested in the technical literature.

What is not contested: the equity stakes are real. The LOIs are signed. The U.S. government is now inside nine quantum companies' cap tables, holding non-controlling positions in firms that collectively span every major hardware approach still in commercial development. If any of those companies exits — via acquisition, IPO, or strategic sale — Commerce participates. If any of those companies licenses its technology to a defense contractor or a foreign subsidiary, Commerce has visibility. The diversified quantum portfolio is not a metaphor. It is a cap table.

For quantum investors, founders, and strategic planners, the implication is concrete: the U.S. government has aligned its financial interests with the success of every major quantum hardware approach simultaneously. That creates a new kind of stakeholder inside the industry — one whose motives are national security and technological leadership, not return on investment, but whose presence in the cap table reshapes the leverage dynamic in ways that a standard federal grant never would.

The LOIs are letters of intent. They are not factories. The superconducting wafers Anderon will produce do not exist yet. The neutral-atom scaling Atom Computing is targeting remains an engineering challenge. PsiQuantum's photonic architecture is still years from the qubit counts that would make it commercially relevant. Federal funding accelerates roadmaps. It does not eliminate the distance between where the industry is and where it needs to be.

But the foundry structure is the part that makes this different from a standard federal R&D package. Washington is no longer just buying quantum research. It is buying quantum manufacturing infrastructure — and, through Anderon, positioning itself as the potential fab of last resort for whichever quantum architecture survives.